Speeches

As the title indicates, the settlement of pharmaceutical patent disputes is a subject that I have already addressed.(1) You may wonder why I am visiting it again. When I first discussed the issue last

Introduction

My topic for today is predation, with specific emphasis on price predation.(1) The topic is timely for a couple of reasons. First, most of the "post-Chicago" commentary seems to have

The title of this speech should be taken literally. The reference to one man emphasizes that I am just speaking for myself. This is the standard disclaimer from people in a federal agency, but I flag

I. Introduction

The interface between intellectual property law and competition is a challenging subject that is a relatively new one for me. For a variety of reasons my individual private practice did

The FTC's investigation of the Midwest Gasoline price spike found no evidence of any anti-trust violations. In my view the main culprit was the introduction of Phase II reformulated gasoline and the

Introduction and Disclaimer

Good morning. I am very pleased to have an opportunity to participate in a discussion of a number of issues of international interest.

Some of the topics I will briefly

I. Introduction

I appreciate the opportunity to present this overview of developments at the Bureau of Competition over the last twelve months.(1) I have the distinct honor of succeeding Rich Parker

A. INTRODUCTION

The essential feature that is new about the "New Economy" is its increased dependence on products and services that are the embodiment of ideas. Examples include such diverse products

Senator Prentice and members of the Committee, I am Charles Harwood, Director of the Northwest Region of the Federal Trade Commission ("FTC" or "Commission").(1) I appreciate the opportunity to

People who labor in and around the law are naturally wary of commentary that begins with praise. They have learned, for example, that appellate court opinions that start with references to the

1. Introduction

I want to thank the Healthcare Antitrust Forum for the invitation to talk about some recent developments in healthcare antitrust at the FTC.(1) An agency representative's usual

I. Introduction

This conference symbolizes a new beginning in the privacy arena. My focus will be on general issues of Internet Privacy and the Federal Trade Commission's role in this area. I hope

It is a delight for me to participate in this panel on Merger Control in an International Context, and to join my enforcement colleagues and friends, Alex Schaub and Joel Klein, in this discussion

Good evening. I'm glad to be here tonight to offer some thoughts as to whether government antitrust enforcement is the "friend or foe" of the tech world.

Is antitrust enforcement is a "friend" or "foe

It is a pleasure to be with you this afternoon. As is always the case for Federal Trade Commissioners, it is important for me to note that my comments today are my own and in no way represent the

Introduction

The electronic marketplace promises to grow at a stunning rate. Consumers can shop around the clock from merchants around the world. Likewise, businesses can reach customers worldwide

Given the readership of ANTITRUST REPORT, I know that many of you frequently wander the halls of the Federal Trade Commission, often with clients in tow. Each of you probably has developed your own

The Commission has recently taken two enforcement actions with a potentially significant effect on distribution law. The first is a series of consent agreements involving cooperative advertising in

I am pleased to be here today in Boston - - the cradle of American liberty - - to discuss the impact of technology on the future of e-commerce and the financial services industry. At the outset, I